Asymptomatic hyperuricemia is independently associated with an increased risk of developing kidney stones. Combining iodinated contrast medium with DECT enhanced the detection of monosodium urate crystals in gout. YouTube videos offering dietary recommendations for patients with gout often diverge from evidence-based guidelines. COVID-19 vaccination was linked to increased early gout flares in patients with infrequent previous flare episodes. Patients with gout are at an increased risk of carotid atherosclerosis. The presence of hyperechoic crystal deposition was associated with hyperuricemia as well as with ischemic nephropathy. Serum uric acid level was an independent influence factor for cardiovascular disease, as well as kidney disease. A study using FibroScan imaging revealed a high prevalence of nonalcoholic fatty liver disease in gout patients. Dual-energy CT showed increased accuracy over ultrasound in detecting tophi. Use of proton pump inhibitors was associated with an increased risk of developing gout. Gout was associated with a threefold increased risk of CVD and a sevenfold increased risk of heart failure in Black patients. Hyperuricemia and gout were associated with a higher risk of long-term mortality in patients with heart failure. Methotrexate and pegloticase resulted in high response rates, improved tophi resolution , and sustained therapeutic benefits. Maintaining a healthy sleep pattern is associated with a lower risk of developing gout. Women with gout were older and had a higher prevalence of heart failure, obesity, UTI, diabetes, dyslipidemia, and CKD. The use of SGLT2 inhibitors in patients with type 2 diabetes was associated with a 34% decreased risk of developing gout. There is a high prevalence of traditional CVD risk factors among patients with gout in secondary care. A study found a strong positive correlation between the volume of MSU crystals and the degree of bone erosion. Gout episodes were found to be associated with increased risk of major cardiovascular events. Gout has shown a potential protective effect against all-cause dementia, Alzheimer’s disease, and vascular dementia.